Oncothyreon Inc (ONTY.OQ)

ONTY.OQ on NASDAQ Stock Exchange Global Select Market

1.78USD
10:50am EDT
Price Change (% chg)

$0.06 (+3.49%)
Prev Close
$1.72
Open
$1.73
Day's High
$1.80
Day's Low
$1.73
Volume
94,444
Avg. Vol
219,200
52-wk High
$6.24
52-wk Low
$1.56

ONTY.OQ

Chart for ONTY.OQ

About

Oncothyreon Inc. (Oncothyreon) is a clinical-stage biopharmaceutical company focused primarily on the development of therapeutic products for the treatment of cancer. The Company’s cancer vaccines are designed to stimulate the immune system to attack cancer cells, while its small molecule compounds are designed to inhibit the... (more)

Overall

Beta: 1.74
Market Cap (Mil.): $107.01
Shares Outstanding (Mil.): 62.22
Dividend: --
Yield (%): --

Financials

  ONTY.OQ Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -0.38 -- --
ROI: -30.77 -2.58 18.76
ROE: -36.27 -2.66 19.59
Search Stocks

Competitors

  Price Change
Pfizer Inc. (PFE.N) $29.18 -0.05
Novartis AG (NOVN.VX) CHF66.60 +0.35
Roche Holding Ltd. (ROG.VX) CHF228.00 -3.50
Abbott Laboratories (ABT.N) $36.92 +0.29
Bayer AG (BAYGn.DE) €89.07 +1.72
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €76.26 -3.91
GlaxoSmithKline plc (GSK.L) 1,706.50p +22.50
Eli Lilly & Co. (LLY.N) $53.23 +0.12
Teva Pharmaceutical Industries Limited (TEVA.TA) 13,920.00₪ -200.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$58.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks